Pinned Tweet
The AI Revolution in Cancer:
Grab your musket & don't wait for a silver bullet.
Ask any AI frontier lab leader what AI will do for humanity and "cure cancer" tops every list.
The image is always the same: miracle drugs. That's not how it's actually playing out.
...
Congrats @kevinweil, @dpatil and the @warpsciences team!
Every AI-for-science bet eventually hits the same wall: going from moving bits to moving atoms. Cutting the latency of that atom-moving loop - automated labs that learn from every run - changes the economics of entire industries. And building this in the US matters for national security as much as for the people developing new medicines.
Can’t imagine a better crew to make this happen 🦾
💥 Introducing Warp Sciences, a new company applying AI and robotics to help the world develop new medicines faster.
We’ve raised a $215M Series A led by @lightspeedvp to bring frontier AI out of the browser and into the lab, and build scientific capacity here in America.
I co-founded Warp with my long-time friend @dpatil, FAIR co-founder @manohar_paluri, and drug hunter Sol Reisberg. The early team is full of incredible people like @bkspears9, who helped achieve Q>1 fusion at LLNL.
Othman Laraki retweeted
The cancer center of the future will be virtual first
From Google to cancer care, Othman Laraki (@othman), Co-Founder and CEO of Color Health (@color), is rethinking how patients access cancer expertise.
In an interview with OncoDaily, he discusses virtual-first cancer care, AI-supported clinical services, earlier diagnosis, and the need to close the gap between scientific advances and everyday practice.
His vision: making access to high-quality cancer care less dependent on geography.
Read the full interview by Dr Gevorg Tamamyan (@GevTamamyan) in the October issue of OncoDaily Magazine: oncodaily.com/magazine/cance…
Othman Laraki retweeted
I don't think people realize how bad this is.
Colorectal cancer is now the leading cause of cancer death in Americans under 50.
In adults 65 and older, incidence is falling 2.5% a year. In adults 20 to 49, it's rising 3% a year.
What's causing this?
😂
Interviewer: If free will is overrated, what's the point of living? Since everything is effectively laid out before you go through it.
Jürgen: Well, they made a movie about that, and it's called Free Willy.
Interviewer: About the whale?
Jürgen: Yeah.
Interviewer: Wait, so, sorry, can you, how does that connect to the question?
Jürgen: It doesn't connect at all. It was just something that I made up.
Huge milestone to see the @AllofUsResearch data release of one of @NIH largest ever projects, where @Color was a major contributor. Proud moment for us and we hope a big step in biomedical research.
nytimes.com/2026/06/30/scien…
Othman Laraki retweeted
A Nature Medicine study found general-purpose LLMs are now outperforming dedicated medical AI products on physician-reviewed clinical tasks.
The authors compared OpenEvidence and UpToDate Expert AI with GPT-5.2, Gemini 3.1 Pro, and Claude Opus 4.6 on medical exam questions, clinician-style answers, and real questions doctors asked during care.
In 100 de-identified physician questions from live clinical use, blinded clinicians again preferred the frontier models, especially on completeness and clarity,
Othman Laraki retweeted
Nearly 90% of large employers now cite cancer as one of their top three cost drivers.
In a new Nasdaq.com op ed, PICI CEO @DrKarenKnudsen and @Color CEO @othman discuss what they call“the triple wave” driving this trend: rising cancer diagnoses among younger populations, increased complex and costly treatments, and a growing survivor workforce requiring long-term treatment.
In the piece, they outline steps employers can take to move from reactive management to proactive cancer care strategies.
Read the full piece here: nasdaq.com/articles/how-canc…
